"The Morning Briefing" is SmartPlanet's daily roundup of must-reads from the web. This morning we're reading about the future of stem cell research.
1.) Israel adult stem cell trials -- hope for ALS patients? A clinical trial of ALS patients conducted by BrainStorm Cell Therapeutics shows its adult stem cell therapy is well-tolerated, appears to be safe and does not present undue risk, according to an interim safety review.
2.) Stem cells show promise as heart failure treatment. In cellular and animal studies, a key protein helped the cells rejuvenate damaged cardiac tissue.
3.) Type one diabetes reversed with stem cells from cord blood. Stem cells from cord blood "re-taught" the immune system T-cells in type one diabetics so that their pancrei began to produce insulin, thereby reducing the amount of insulin they need to inject. Dr. Yong Zhao from the University of Illinois at Chicago published these findings online in an open access journal.
4.) Stem cell therapy: Cure for autism? Parents of children with autism, or other developmental condition for that matter, go to great lengths to find a "cure’" for their children. Even though these may not exist yet for most conditions, parents exhaust all possible means to look for ways to improve the lives of their children.
5.) 21 spine surgeons researching stem cell treatments featured. Here are 21 spine surgeons who are involved in stem cell research for spinal treatment.
Image credit: Andreas Nieto Porras
This post was originally published on Smartplanet.com